Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 1/2014

Open Access 01-03-2014 | Meeting abstract

Comparison of questionnaire responses with biomarkers of tobacco smoke exposure in a Canadian birth cohort at three months of age

Authors: Kathleen McLean, Bruce Lanphear, Amanda J Wheeler, Jeff Brook, James Scott, Ryan Allen, Michael Brauer, Malcolm Sears, Padmaja Subbarao, Stuart Turvey, Allan Becker, Piush Mandhane, Tim Takaro

Published in: Allergy, Asthma & Clinical Immunology | Special Issue 1/2014

Login to get access

Excerpt

Exposure to tobacco smoke increases the risk for several adverse health effects in children including wheeze, asthma, and asthma exacerbation [1, 2]. Accurately assessing tobacco smoke exposure is important for understanding and preventing these health effects. Questionnaires are a flexible and relatively inexpensive method of assessing exposure, but biomarkers of tobacco smoke exposure are considered more accurate. We developed questionnaire-based exposure models predicting urinary levels of biomarkers cotinine and trans-3’-hydroxycotinine (3HC) (metabolites of nicotine) in 3-month old infants using parent-reported questionnaire responses about tobacco smoke exposure from the Canadian Healthy Infant Longitudinal Development (CHILD) Study. …
Literature
1.
go back to reference Committee on the Assessment of Asthma and Indoor Air, Division of Health Promotion and Disease Prevention, Institute of Medicine: Clearing the Air: Asthma and Indoor Air Exposures. 2000, Washington, DC: National Academy Press Committee on the Assessment of Asthma and Indoor Air, Division of Health Promotion and Disease Prevention, Institute of Medicine: Clearing the Air: Asthma and Indoor Air Exposures. 2000, Washington, DC: National Academy Press
2.
go back to reference U.S. Department of Health and Human Services: The Health Consequences of Involuntary Exposure to Tobacco Smoke. A Report of the Surgeon General. 2006, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, [Publications and Reports of the Surgeon General] U.S. Department of Health and Human Services: The Health Consequences of Involuntary Exposure to Tobacco Smoke. A Report of the Surgeon General. 2006, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, [Publications and Reports of the Surgeon General]
3.
go back to reference Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL: Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004, 76: 64-72.CrossRefPubMed Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL: Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004, 76: 64-72.CrossRefPubMed
4.
go back to reference Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, Murphy M, Walton R: Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther. 2006, 80: 319-330.CrossRefPubMed Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, Murphy M, Walton R: Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther. 2006, 80: 319-330.CrossRefPubMed
Metadata
Title
Comparison of questionnaire responses with biomarkers of tobacco smoke exposure in a Canadian birth cohort at three months of age
Authors
Kathleen McLean
Bruce Lanphear
Amanda J Wheeler
Jeff Brook
James Scott
Ryan Allen
Michael Brauer
Malcolm Sears
Padmaja Subbarao
Stuart Turvey
Allan Becker
Piush Mandhane
Tim Takaro
Publication date
01-03-2014
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1710-1492-10-S1-A60

Other articles of this Special Issue 1/2014

Allergy, Asthma & Clinical Immunology 1/2014 Go to the issue